Which discharge medication is NOT typically prescribed for post-CABG patients?

The choice of warfarin as a medication not typically prescribed for post-CABG patients is accurate. In the context of post-coronary artery bypass graft (CABG) surgery, the primary goals of medication management focus on preventing thrombosis in the grafts and managing cardiovascular risk factors. Aspirin and clopidogrel are antiplatelet agents commonly prescribed after CABG to reduce the risk of thromboembolic events and to protect the patency of the grafts. Beta blockers are also routinely given to manage heart rate, reduce myocardial oxygen demand, and improve postoperative outcomes.

Warfarin, on the other hand, is an anticoagulant that is generally not indicated for routine use after CABG surgery unless there are specific conditions present that warrant its use, such as the presence of atrial fibrillation or mechanical heart valves. The routine administration of warfarin after CABG can increase the risk of bleeding complications, especially in the early recovery phase when patients are at heightened risk due to surgical interventions. Thus, it is not a standard part of the post-discharge medication regimen for most patients who have undergone CABG.